<DOC>
	<DOC>NCT00089687</DOC>
	<brief_summary>The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.</brief_summary>
	<brief_title>GBR 12909 Study in Cocaine Experienced African American Volunteers - 1</brief_title>
	<detailed_description>Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Vanoxerine</mesh_term>
	<criteria>Must be within 20% of ideal body weight and must weigh at least 45 kg. Must understand the study procedures and provide written informed consent. Must meet DSM4 criteria for abuse or dependence on cocaine. Must be nontreatment seeking at the time of the study. Please contact the study site for more information.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2005</verification_date>
</DOC>